Frontiers in Oncology | Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers

Original Research

Published on 01 Jul 2025

The association between nutritional risk and survival time among patients with pancreatic cancer following pancreaticoduodenectomy: a retrospective cohort study

in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers

Qiuju Tian
Jing Su
Leying Chen
Min Zhang
Beiwen Wu
Baiyong Shen

Frontiers in Oncology

doi 10.3389/fonc.2025.1539215

283 views

Case Report

Published on 01 Jul 2025

Primary hepatic leiomyosarcoma concurrent with early-stage lung adenocarcinoma: a rare case report

in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers

Weizhong Peng
Xiaohui Xiao
Lu Li
Yi Yu

Frontiers in Oncology

doi 10.3389/fonc.2025.1621686

278 views

Original Research

Accepted on 30 Jun 2025

Efficacy and safety of TACE-HAIC combined with tyrosine kinase inhibitors and immune checkpoint inhibitors for the patients with BCLC-defined stage B-C HCC

in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers

Bowen Liu
Linan Yin
Yuxin Chen
Xunbo Hou
Yingchen Li
Xuesong Liu
RuiBao Liu

Frontiers in Oncology

doi 10.3389/fonc.2025.1615506

Original Research

Accepted on 30 Jun 2025

Development and Validation of a Nomogram Based on Muscle and Intermuscular Adipose Tissue to Predict Long-Term Survival in Intrahepatic Cholangiocarcinoma Patients

in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers

Changfeng Cheng
Yuxin Chen
Puchuang Xu
Jiatao Song
Yuqian Gan
Yurong Wang
Xin Zhao
Shiying Huang
Hanxu Wang
Gang Chen

Frontiers in Oncology

doi 10.3389/fonc.2025.1598042

Systematic Review

Accepted on 30 Jun 2025

Bibliometric Analysis of Pancreatic Cancer Liver Metastasis Research: Global Trends, Collaborations, and Emerging Research Hotspots

in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers

Yingjie Huang
Zhijie Yin
Wei Han

Frontiers in Oncology

doi 10.3389/fonc.2025.1546400

173 views

Original Research

Accepted on 30 Jun 2025

DCP as a Biomarker for TACE Efficacy in Hepatocellular Carcinoma

in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers

Hui Xie
Youwei Li
Jie Yang
Yuwei Tan
Jin Xu
Xiao Yang

Frontiers in Oncology

doi 10.3389/fonc.2025.1560210

Original Research

Accepted on 30 Jun 2025

A Multi-Algorithm Prognostic Model Combining Inflammatory Indices and Surgical Features in Distal Cholangiocarcinoma

in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers

Yi Yin
Luyuan Bai
Xinyue Mu
Shan Zhang
Panpan Zhai

Frontiers in Oncology

doi 10.3389/fonc.2025.1625703

Systematic Review

Accepted on 26 Jun 2025

Global research trends and hotspots in prognostic prediction models for pancreatic cancer: a bibliometric analysis

in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers

Siyuan Ouyang
Jing Zhang
Fuyao Liu
Qi Jiang
Wei Xing
Jie Chen
Jinggang Zhang

Frontiers in Oncology

doi 10.3389/fonc.2025.1588735

133 views

Case Report

Accepted on 26 Jun 2025

Undifferentiated embryonic sarcoma of the adult liver: a case report

in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers

Shengyong Li
Lexin Bao
Xiujun Li
Liang Bai

Frontiers in Oncology

doi 10.3389/fonc.2025.1599953

Editorial

Accepted on 26 Jun 2025

Editorial: Molecular Markers for Pancreatic Cancers: New Technologies and Applications in the Clinical Practice

in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers

Terence Moyana
Valeria Merz

Frontiers in Oncology

doi 10.3389/fonc.2025.1651566

123 views

Original Research

Published on 26 Jun 2025

The development of pancreatic cancer is accompanied by significant changes in the immune response in genetically predisposed mice

in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers

Urszula Daniluk
Agnieszka Świdnicka-Siergiejko
Jarosław Daniluk
Małgorzata Rusak
Milena Dąbrowska
Katarzyna Guzińska-Ustymowicz
Anna Pryczynicz
Andrzej Dąbrowski

Frontiers in Oncology

doi 10.3389/fonc.2025.1603293

350 views

Original Research

Published on 26 Jun 2025

Investigating the correlation between tertiary lymphoid structures and clinical outcomes in pancreatic ductal adenocarcinoma: insights into tumor immunology

in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers

Lingbo Hu
Yanhong Xiao
Ning Jiang
Yufen Hu
Liewang Qiu
Bo Geng

Frontiers in Oncology

doi 10.3389/fonc.2025.1569947

406 views

Review

Published on 26 Jun 2025

The human microbiota: a double-edged sword against the ‘Sword of Damocles’ in PDAC diagnosis and therapy

in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers

Maria Sindaco
Leonardo Mercanti
Valentina Puca
Mariangela Mazzone
Maria Carmela Di Marcantonio
Raffaella Muraro
Michele Fiordaliso
Gabriella Mincione

Frontiers in Oncology

doi 10.3389/fonc.2025.1519277

321 views

Original Research

Accepted on 24 Jun 2025

Efficacy and Safety of D-TACE Followed by D-RFA for Unresectable Large Hepatocellular Carcinoma

in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers

Pang Qingqing
Luo Wenping
Chen Shaojun
Zhou Hua
Zhang Riguang
Li Yueyong
Jianbo Zhao
Chunwang Yuan
Wang Guodong

Frontiers in Oncology

doi 10.3389/fonc.2025.1530951

106 views

Original Research

Accepted on 23 Jun 2025

Nomogram based on tumor burden score for prediction of prognosis of patients with hepatocellular carcinoma before hepatectomy

in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers

Qianru Xiao
Zhengqing Lei
Anfeng Si
Xuewu Tang
Facai Yang
Weihu Ma
Cheng Chi
Qiushi Yu
Yigang He
Haolan Tang

Frontiers in Oncology

doi 10.3389/fonc.2025.1578859

Correction

Accepted on 20 Jun 2025

Correction: HIF-1α Modulates Pancreatic Cancer ECM Proteins via the TGF-β1/Smad Signaling

in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers

Linxun Liu

Frontiers in Oncology

doi 10.3389/fonc.2025.1648986

108 views